"Designing Growth Strategies is in our DNA"

Cardiac Troponin Market Size, Share & Industry Analysis, By Type (Troponin T and Troponin I), By Setting (Laboratory Testing and Point-of-Care (POC) Testing), By Indication (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, and Others) By End User (Hospitals & Clinics, Diagnostic Laboratories, and Homecare Settings & Others), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101234

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Cardiovascular Diseases, By Key Countries/Regions, 2022/2023
    2. Technological Advancements in Cardiac Troponin Testing
    3. New Product Launches. By Key Players
    4. Key Industry Developments (Mergers, Acquisitions, Partnerships etc.)
    5. Impact of COVID-19 on the Market
  5. Global Cardiac Troponin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Troponin T
      2. Troponin I
    2. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of-Care (POC) Testing
    3. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    4. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Homecare Settings & Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Cardiac Troponin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Troponin T
      2. Troponin I
    2. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of-Care (POC) Testing
    3. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    4. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Homecare Settings & Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Cardiac Troponin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Troponin T
      2. Troponin I
    2. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of-Care (POC) Testing
    3. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    4. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Homecare Settings & Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
  8. Asia Pacific Cardiac Troponin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Troponin T
      2. Troponin I
    2. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of-Care (POC) Testing
    3. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    4. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Homecare Settings & Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Rest of Asia Pacific
  9. Latin America Cardiac Troponin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Troponin T
      2. Troponin I
    2. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of-Care (POC) Testing
    3. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    4. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Homecare Settings & Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Cardiac Troponin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Troponin T
      2. Troponin I
    2. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of-Care (POC) Testing
    3. Market Analysis, Insights and Forecast – By Indication
      1. Myocardial Infarction
      2. Congestive Heart Failure
      3. Acute Coronary Syndrome
      4. Others
    4. Market Analysis, Insights and Forecast – By End-User
      1. Hospitals & Clinics
      2. Diagnostic Laboratories
      3. Homecare Settings & Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. bioMérieux SA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Siemens Healthineers AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Eurolyser Diagnostica GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. QuidelOrtho (Quidel Corporation)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. PerkinElmer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Beckman Coulter, Inc. (Danaher)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. RESPONSE BIOMEDICAL
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. LifeSign LLC.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: Global Cardiac Troponin Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global Cardiac Troponin Market Value Share (%), By Type, 2023 & 2032

Figure 3: Global Cardiac Troponin Market Value Share (%), by Setting, 2023 & 2032

Figure 4: Global Cardiac Troponin Market Value Share (%), by Indication, 2023 & 2032

Figure 5: Global Cardiac Troponin Market Value Share (%), by End-User, 2023 & 2032

Figure 6: Global Cardiac Troponin Market Value (USD billion), by Region, 2023 & 2032

Figure 7: North America Cardiac Troponin Market Value (USD billion), By Type, 2023 & 2032

Figure 8: North America Cardiac Troponin Market Value Share (%), By Type, 2023

Figure 9: North America Cardiac Troponin Market Value (USD billion), by Setting, 2023 & 2032

Figure 10: North America Cardiac Troponin Market Value Share (%), by Setting, 2023

Figure 11: North America Cardiac Troponin Market Value (USD billion), by Indication, 2023 & 2032

Figure 12: North America Cardiac Troponin Market Value Share (%), by Indication, 2023

Figure 13: North America Cardiac Troponin Market Value (USD billion), by End-User, 2023 & 2032

Figure 14: North America Cardiac Troponin Market Value Share (%), by End-User, 2023

Figure 15: North America Cardiac Troponin Market Value (USD billion), By Country, 2023 & 2032

Figure 16: North America Cardiac Troponin Market Value Share (%), By Country, 2023

Figure 17: Europe Cardiac Troponin Market Value (USD billion), By Type, 2023 & 2032

Figure 18: Europe Cardiac Troponin Market Value Share (%), By Type, 2023

Figure 19: Europe Cardiac Troponin Market Value (USD billion), by Setting, 2023 & 2032

Figure 20: Europe Cardiac Troponin Market Value Share (%), by Setting, 2023

Figure 21: Europe Cardiac Troponin Market Value (USD billion), by Indication, 2023 & 2032

Figure 22: Europe Cardiac Troponin Market Value Share (%), by Indication, 2023

Figure 23: Europe Cardiac Troponin Market Value (USD billion), by End-User, 2023 & 2032

Figure 24: Europe Cardiac Troponin Market Value Share (%), by End-User, 2023

Figure 25: Europe Cardiac Troponin Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 26: Europe Cardiac Troponin Market Value Share (%), By Country/ Sub-region, 2023

Figure 27: Asia Pacific Cardiac Troponin Market Value (USD billion), By Type, 2023 & 2032

Figure 28: Asia Pacific Cardiac Troponin Market Value Share (%), By Type, 2023

Figure 29: Asia Pacific Cardiac Troponin Market Value (USD billion), by Setting, 2023 & 2032

Figure 30: Asia Pacific Cardiac Troponin Market Value Share (%), by Setting, 2023

Figure 31: Asia Pacific Cardiac Troponin Market Value (USD billion), by Indication, 2023 & 2032

Figure 32: Asia Pacific Cardiac Troponin Market Value Share (%), by Indication, 2023

Figure 33: Asia Pacific Cardiac Troponin Market Value (USD billion), by End-User, 2023 & 2032

Figure 34: Asia Pacific Cardiac Troponin Market Value Share (%), by End-User, 2023

Figure 35: Asia Pacific Cardiac Troponin Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 36: Asia Pacific Cardiac Troponin Market Value Share (%), By Country/ Sub-region, 2023

Figure 37: Latin America Cardiac Troponin Market Value (USD billion), By Type, 2023 & 2032

Figure 38: Latin America Cardiac Troponin Market Value Share (%), By Type, 2023

Figure 39: Latin America Cardiac Troponin Market Value (USD billion), by Setting, 2023 & 2032

Figure 40: Latin America Cardiac Troponin Market Value Share (%), by Setting, 2023

Figure 41: Latin America Cardiac Troponin Market Value (USD billion), by Indication, 2023 & 2032

Figure 42: Latin America Cardiac Troponin Market Value Share (%), by Indication, 2023

Figure 43: Latin America Cardiac Troponin Market Value (USD billion), by End-User, 2023 & 2032

Figure 44: Latin America Cardiac Troponin Market Value Share (%), by End-User, 2023

Figure 45: Latin America Cardiac Troponin Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 46: Latin America Cardiac Troponin Market Value Share (%), By Country/ Sub-region, 2023

Figure 47: Middle East & Africa Cardiac Troponin Market Value (USD billion), By Type, 2023 & 2032

Figure 48: Middle East & Africa Cardiac Troponin Market Value Share (%), By Type, 2023

Figure 49: Middle East & Africa Cardiac Troponin Market Value (USD billion), by Setting, 2023 & 2032

Figure 50: Middle East & Africa Cardiac Troponin Market Value Share (%), by Setting, 2023

Figure 51: Middle East & Africa Cardiac Troponin Market Value (USD billion), by Indication, 2023 & 2032

Figure 52: Middle East & Africa Cardiac Troponin Market Value Share (%), by Indication, 2023

Figure 53: Middle East & Africa Cardiac Troponin Market Value (USD billion), by End-User, 2023 & 2032

Figure 54: Middle East & Africa Cardiac Troponin Market Value Share (%), by End-User, 2023

Figure 55: Middle East & Africa Cardiac Troponin Market Value (USD billion), By Country/ Sub-region, 2023 & 2032s

Figure 56: Middle East & Africa Cardiac Troponin Market Value Share (%), By Country/ Sub-region, 2023

Figure 57: Global Cardiac Troponin Market Share (%), By Company, 2023 

Table 1: Global Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2: Global Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2019–2032

Table 3: Global Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 4: Global Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2019–2032

Table 5: Global Cardiac Troponin Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 6: North America Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 7: North America Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2019-2032

Table 8: North America Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 9: North America Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2019-2032

Table 10: North America Cardiac Troponin Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 11: Europe Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 12: Europe Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2019-2032

Table 13: Europe Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 14: Europe Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2019-2032

Table 15: Europe Cardiac Troponin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Asia Pacific Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 17: Asia Pacific Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2019-2032

Table 18: Asia Pacific Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 19: Asia Pacific Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2019-2032

Table 20: Asia Pacific Cardiac Troponin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 21: Latin America Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 22: Latin America Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2019-2032

Table 23: Latin America Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 24: Latin America Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2019-2032

Table 25: Latin America Cardiac Troponin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 26: Middle East & Africa Cardiac Troponin Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 27: Middle East & Africa Cardiac Troponin Market Revenue (USD billion) Forecast, by Setting, 2019-2032

Table 28: Middle East & Africa Cardiac Troponin Market Revenue (USD billion) Forecast, by Indication, 2019-2032

Table 29: Middle East & Africa Cardiac Troponin Market Revenue (USD billion) Forecast, by End-User, 2019-2032

Table 30: Middle East & Africa Cardiac Troponin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

  • 2019-2032
  • 2023
  • 2019-2022
  • 150
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase